1	Age-related	age-related	_	_	_	_	_	_	_
2	decreases	decrease	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	IL-2	il-2	_	_	_	_	_	_	_
5	production	production	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	are	be	_	_	_	_	_	_	_
11	associated	associate	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	impaired	impaired	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	nuclear	nuclear	_	_	_	_	_	_	_
17	transcriptional	transcriptional	_	_	_	_	_	_	_
18	factors	factor	_	_	_	_	_	_	_
19	AP-1	ap-1	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	NF-AT	NF-AT	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	transcriptional	transcriptional	_	_	_	_	_	_	_
3	factors	factor	_	_	_	_	_	_	_
4	AP-1	ap-1	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	activated	activate	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	NF-AT	NF-AT	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	are	be	_	_	_	_	_	_	_
16	important	important	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	normal	normal	_	_	_	_	_	_	_
20	induction	induction	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	IL-2	il-2	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	it	it	_	_	_	_	_	_	_
25	is	be	_	_	_	_	_	_	_
26	unknown	unknown	_	_	_	_	_	_	_
27	if	if	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	age-related	age-related	_	_	_	_	_	_	_
30	decline	decline	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	IL-2	il-2	_	_	_	_	_	_	_
33	production	production	_	_	_	_	_	_	_
34	by	by	_	_	_	_	_	_	_
35	activated	activate	_	_	_	_	_	_	_
36	human	human	_	_	_	_	_	_	_
37	T	t	_	_	_	_	_	_	_
38	cells	cell	_	_	_	_	_	_	_
39	may	may	_	_	_	_	_	_	_
40	be	be	_	_	_	_	_	_	_
41	associated	associate	_	_	_	_	_	_	_
42	with	with	_	_	_	_	_	_	_
43	aberrancies	aberrancy	_	_	_	_	_	_	_
44	in	in	_	_	_	_	_	_	_
45	transcriptional	transcriptional	_	_	_	_	_	_	_
46	regulatory	regulatory	_	_	_	_	_	_	_
47	proteins	protein	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	current	current	_	_	_	_	_	_	_
4	studies	study	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	production	production	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	elderly	elderly	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	mean	mean	_	_	_	_	_	_	_
15	78	78	_	_	_	_	_	_	_
16	years	year	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	young	young	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	mean	mean	_	_	_	_	_	_	_
22	37	37	_	_	_	_	_	_	_
23	years	year	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	humans	human	_	_	_	_	_	_	_
26	was	be	_	_	_	_	_	_	_
27	measured	measure	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	cultures	culture	_	_	_	_	_	_	_
30	stimulated	stimulate	_	_	_	_	_	_	_
31	with	with	_	_	_	_	_	_	_
32	PHA	PHA	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	PHA	PHA	_	_	_	_	_	_	_
35	plus	plus	_	_	_	_	_	_	_
36	PMA	PMA	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	crosslinked	crosslinke	_	_	_	_	_	_	_
39	anti-CD3	anti-cd3	_	_	_	_	_	_	_
40	mAB	mAB	_	_	_	_	_	_	_
41	OKT3	OKT3	_	_	_	_	_	_	_
42	plus	plus	_	_	_	_	_	_	_
43	PMA	PMA	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	or	or	_	_	_	_	_	_	_
46	PMA	PMA	_	_	_	_	_	_	_
47	plus	plus	_	_	_	_	_	_	_
48	ionomycin	ionomycin	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

1	Substantial	substantial	_	_	_	_	_	_	_
2	decreases	decrease	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	IL-2	il-2	_	_	_	_	_	_	_
5	production	production	_	_	_	_	_	_	_
6	were	be	_	_	_	_	_	_	_
7	observed	observe	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	cultures	culture	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	7	7	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	12	12	_	_	_	_	_	_	_
15	elderly	elderly	_	_	_	_	_	_	_
16	individuals	individual	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	response	response	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	different	different	_	_	_	_	_	_	_
22	stimuli	stimulus	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	whereas	whereas	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	levels	level	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	IL-2	il-2	_	_	_	_	_	_	_
29	produced	produce	_	_	_	_	_	_	_
30	by	by	_	_	_	_	_	_	_
31	stimulated	stimulate	_	_	_	_	_	_	_
32	T	t	_	_	_	_	_	_	_
33	cells	cell	_	_	_	_	_	_	_
34	from	from	_	_	_	_	_	_	_
35	other	other	_	_	_	_	_	_	_
36	elderly	elderly	_	_	_	_	_	_	_
37	individuals	individual	_	_	_	_	_	_	_
38	were	be	_	_	_	_	_	_	_
39	equivalent	equivalent	_	_	_	_	_	_	_
40	to	to	_	_	_	_	_	_	_
41	those	those	_	_	_	_	_	_	_
42	observed	observe	_	_	_	_	_	_	_
43	for	for	_	_	_	_	_	_	_
44	stimulated	stimulate	_	_	_	_	_	_	_
45	T	t	_	_	_	_	_	_	_
46	cells	cell	_	_	_	_	_	_	_
47	of	of	_	_	_	_	_	_	_
48	young	young	_	_	_	_	_	_	_
49	subjects	subject	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

1	Analyses	analysis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	nuclear	nuclear	_	_	_	_	_	_	_
4	extracts	extract	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	electrophoretic	electrophoretic	_	_	_	_	_	_	_
7	DNA	dna	_	_	_	_	_	_	_
8	mobility	mobility	_	_	_	_	_	_	_
9	shift	shift	_	_	_	_	_	_	_
10	assays	assay	_	_	_	_	_	_	_
11	showed	show	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	decreased	decrease	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	production	production	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	stimulated	stimulate	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	elderly	elderly	_	_	_	_	_	_	_
22	individuals	individual	_	_	_	_	_	_	_
23	was	be	_	_	_	_	_	_	_
24	closely	closely	_	_	_	_	_	_	_
25	associated	associate	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	impairments	impairment	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	activation	activation	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	both	both	_	_	_	_	_	_	_
33	AP-1	ap-1	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	NF-AT	NF-AT	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	T	t	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	elderly	elderly	_	_	_	_	_	_	_
8	subjects	subject	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	normal	normal	_	_	_	_	_	_	_
11	levels	level	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	IL-2	il-2	_	_	_	_	_	_	_
14	production	production	_	_	_	_	_	_	_
15	exhibited	exhibit	_	_	_	_	_	_	_
16	normal	normal	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	AP-1	ap-1	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	NF-AT	NF-AT	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	results	result	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	competition	competition	_	_	_	_	_	_	_
8	experiments	experiment	_	_	_	_	_	_	_
9	analyzing	analyze	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	normal	normal	_	_	_	_	_	_	_
12	components	component	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	NF-AT	NF-AT	_	_	_	_	_	_	_
15	showed	show	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	age-related	age-related	_	_	_	_	_	_	_
19	reductions	reduction	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	stimulus-dependent	stimulus-dependent	_	_	_	_	_	_	_
22	NF-AT	NF-AT	_	_	_	_	_	_	_
23	complexes	complex	_	_	_	_	_	_	_
24	corresponded	correspond	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	slow	slow	_	_	_	_	_	_	_
28	migrating	migrate	_	_	_	_	_	_	_
29	complexes	complex	_	_	_	_	_	_	_
30	that	that	_	_	_	_	_	_	_
31	were	be	_	_	_	_	_	_	_
32	composed	compose	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	c-Fos/c-Jun	c-fos/c-jun	_	_	_	_	_	_	_
35	AP-1	ap-1	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	resting	resting	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	stimulated	stimulate	_	_	_	_	_	_	_
5	levels	level	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NF	NF	_	_	_	_	_	_	_
8	kappa	kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	reduced	reduce	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	from	from	_	_	_	_	_	_	_
16	certain	certain	_	_	_	_	_	_	_
17	elderly	elderly	_	_	_	_	_	_	_
18	individuals	individual	_	_	_	_	_	_	_
19	;	;	_	_	_	_	_	_	_
20	however	however	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	alterations	alteration	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	NF	NF	_	_	_	_	_	_	_
25	kappa	kappa	_	_	_	_	_	_	_
26	B	B	_	_	_	_	_	_	_
27	did	do	_	_	_	_	_	_	_
28	not	not	_	_	_	_	_	_	_
29	correlate	correlate	_	_	_	_	_	_	_
30	with	with	_	_	_	_	_	_	_
31	changes	change	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	IL-2	il-2	_	_	_	_	_	_	_
34	expression	expression	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	show	show	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	age-related	age-related	_	_	_	_	_	_	_
8	impairments	impairment	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	AP-1	ap-1	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	NF-AT	NF-AT	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	closely	closely	_	_	_	_	_	_	_
18	associated	associate	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	decreased	decrease	_	_	_	_	_	_	_
21	expression	expression	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	IL-2	il-2	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	further	further	_	_	_	_	_	_	_
26	suggest	suggest	_	_	_	_	_	_	_
27	that	that	_	_	_	_	_	_	_
28	aberrancies	aberrancy	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	signaling	signaling	_	_	_	_	_	_	_
32	pathways	pathway	_	_	_	_	_	_	_
33	important	important	_	_	_	_	_	_	_
34	for	for	_	_	_	_	_	_	_
35	the	the	_	_	_	_	_	_	_
36	induction	induction	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	transcriptionally	transcriptionally	_	_	_	_	_	_	_
39	active	active	_	_	_	_	_	_	_
40	c-Fos/c-Jun	c-fos/c-jun	_	_	_	_	_	_	_
41	AP-1	ap-1	_	_	_	_	_	_	_
42	may	may	_	_	_	_	_	_	_
43	contribute	contribute	_	_	_	_	_	_	_
44	to	to	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	impaired	impaired	_	_	_	_	_	_	_
47	activation	activation	_	_	_	_	_	_	_
48	of	of	_	_	_	_	_	_	_
49	NF-AT	NF-AT	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

